ONLINE DATABASE SEARCH - OI-LS-315-MEMO
1. 44827 OI-LS-315; PUBMED-OI-2/9/2005
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
Kapadia, SB and Chisari, FV
Proc Natl Acad Sci U S A 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15699349&dopt=abstract
2. 44828 OI-LS-315; PUBMED-OI-2/9/2005
Synthesis and potent antimicrobial activity of some novel 2-phenyl or methyl-4H-1-benzopyran-4-ones carrying amidinobenzimidazoles
Goker, H, Boykin, DW, and Yildiz, S
Bioorg Med Chem 2005. 13(5): 1707-1714
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698788&dopt=abstract
3. 44829 OI-LS-315; PUBMED-OI-2/9/2005
Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system
Shi, J, Du, J, Ma, T, Pankiewicz, KW, Patterson, SE, Tharnish, PM, McBrayer, TR, Stuyver, LJ, Otto, MJ, Chu, CK, Schinazi, RF, and Watanabe, KA
Bioorg Med Chem 2005. 13(5): 1641-52
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698782&dopt=abstract
4. 44830 OI-LS-315; PUBMED-OI-2/9/2005
Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups
Ozden, S, Atabey, D, Yildiz, S, and Goker, H
Bioorg Med Chem 2005. 13(5): 1587-1597
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698776&dopt=abstract
5. 44831 OI-LS-315; PUBMED-OI-2/9/2005
Synthesis of 4-hydroxy-1-methylindole and benzo[b]thiophen-4-ol based unnatural flavonoids as new class of antimicrobial agents
Yadav, PP, Gupta, P, Chaturvedi, AK, Shukla, PK, and Maurya, R
Bioorg Med Chem 2005. 13(5): 1497-505
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15698765&dopt=abstract
6. 44832 OI-LS-315; PUBMED-OI-2/9/2005
The crystal structure of Rv1347c, a putative antibiotic resistance protein from mycobacterium tuberculosis, reveals a GCN5-related fold and suggests an alternative function in siderophore biosynthesis
Card, GL, Peterson, NA, Smith, CA, Rupp, B, Schick, BM, and Baker, EN
J Biol Chem 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15695811&dopt=abstract
7. 44833 OI-LS-315; SCIFINDER-OI-2/1/2005
Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice
Kamai, Yasuki, Kakuta, Masayo, Shibayama, Takahiro, Fukuoka, Takashi, and Kuwahara, Shogo
Antimicrobial Agents and Chemotherapy 2005. 49(1): 52-56
8. 44834 OI-LS-315; PUBMED-OI-2/9/2005
Drug Resistance and Fitness in Mycobacterium tuberculosis Infection
Bottger, EC, Pletschette, M, and Andersson, D
J Infect Dis 2005. 191(5): 823-4
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15688309&dopt=abstract
9. 44835 OI-LS-315; PUBMED-OI-2/9/2005
Studies on synthesis and evaluation of quantitative structure-activity relationship of 5-[(3'-chloro-4',4'-disubstituted-2-oxoazetidinyl)(N-nitro)amino]-6-hydrox y-3-alkyl/aryl[1,3]azaphospholo[1,5-a]pyridin-1-yl-phosphorus dichlorides
Sharma, P, Kumar, A, Sharma, S, and Rane, N
Bioorg Med Chem Lett 2005. 15(4): 937-43
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15686890&dopt=abstract
10. 44836 OI-LS-315; SCIFINDER-OI-2/1/2005
Effect of sub-inhibitory concentrations of amphotericin B on the yeast surface and phagocytic killing activity
Bahmed, Karim, Bonaly, Roger, Benallaoua, Said, and Coulon, Joel
Process Biochemistry (Oxford, United Kingdom) 2005. 40(2): 759-765
11. 44837 OI-LS-315; PUBMED-OI-2/9/2005
The 1.9 A Crystal Structure of Alanine Racemase from Mycobacterium tuberculosis Contains a Conserved Entryway into the Active Site(,)
Lemagueres, P, Im, H, Ebalunode, J, Strych, U, Benedik, MJ, Briggs, JM, Kohn, H, and Krause, KL
Biochemistry 2005. 44(5): 1471-1481
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15683232&dopt=abstract
12. 44838 OI-LS-315; SCIFINDER-OI-2/1/2005
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug
Jia, Lee, Tomaszewski, Joseph E, Hanrahan, Colleen, Coward, Lori, Noker, Patricia, Gorman, Gregory, Nikonenko, Boris, and Protopopova, Marina
British Journal of Pharmacology 2005. 144(1): 80-87
13. 44839 OI-LS-315; PUBMED-OI-2/9/2005
Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases
Muri, EM, Gomes, M Jr, Albuquerque, MG, da, Cunha EF, de, Alencastro RB, Williamson, JS, and Antunes, OA
Amino Acids 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15662562&dopt=abstract
14. 44840 OI-LS-315; PUBMED-OI-2/9/2005
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis
Takayama, K, Wang, C, and Besra, GS
Clin Microbiol Rev 2005. 18(1): 81-101
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15653820&dopt=abstract
15. 44841 OI-LS-315; SCIFINDER-OI-2/1/2005
Novel HCV shorter form core+1 proteins and polynucleotides for prophylaxis and diagnosis of HCV infections and for screening of anti-HCV agents
Mavromara, Penelope and Niki, Vassilaki
PATENT: EP 1493749 ISSUE DATE: 20050105
APPLICATION: 2003-29532 PP: 80 pp.
ASSIGNEE: (Institut Pasteur, Fr. and Institut Pasteur Hellenique)
16. 44842 OI-LS-315; SCIFINDER-OI-2/1/2005
Amino substituted derivatives of 5'-amino-5'-deoxy-5'-noraristeromycin
Yang, Minmin and Schneller, Stewart W
Bioorganic & Medicinal Chemistry 2005. 13(3): 877-882
17. 44843 OI-LS-315; SCIFINDER-OI-2/1/2005
The road to new antiviral therapies
Jerome, Keith R
Clinical and Applied Immunology Reviews 2005. 5(1): 65-76
18. 44844 OI-LS-315; WOS-OI-1/30/2005
Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole
Khan, MA, Jabeen, R, and Mohammad, O
PHARMACEUTICAL RESEARCH 2004. 21(12): 2207-2212, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226031500009
19. 44845 OI-LS-315; SCIFINDER-OI-2/1/2005
Luciferase reporter gene-based cytotoxicity assays for high throughput dual screening of specificity and cytotoxicity of antiviral agents and antibiotics
Blair, Wade Stanton, Isaacson, Jason Steven, Cao, Joan Qun, and Patick, Amy Karen
PATENT: WO 2004048613 ISSUE DATE: 20040610
APPLICATION: 2003 PP: 56 pp.
ASSIGNEE: (Pfizer Inc., USA
20. 44846 OI-LS-315; WOS-OI-1/30/2005
Synthesis and microbiological evaluation of novel [N-acetyl-2,6-diarylpiperidin-4-yl]-5-spiro-4-ace yl-2-(acetylamino)-Delta(2)-1,3,4-thiadiazolines
Balasubramanian, S, Ramalingan, C, Aridoss, G, Parthiban, P, and Kabilan, S
MEDICINAL CHEMISTRY RESEARCH 2004. 13(5): 297-311, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226106600004
21. 44847 OI-LS-315; SCIFINDER-OI-2/1/2005
Steroidal glucocorticoid receptor antagonist antiviral compositions and methods of use
Kim, Jong Joseph
PATENT: WO 2004112720 ISSUE DATE: 20041229
APPLICATION: 2004 PP: 36 pp.
ASSIGNEE: (Viral Genomix, Inc. USA
22. 44848 OI-LS-315; SCIFINDER-OI-2/1/2005
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
Britt, Shawn D, Cottrell, Kevin M, Perni, Robert B, and Pitlik, Janos
PATENT: WO 2005007681 ISSUE DATE: 20050127
APPLICATION: 2004
ASSIGNEE: (Vertex Pharmaceuticals Incorporated, USA
23. 44849 OI-LS-315; SCIFINDER-OI-2/1/2005
Substituted arylthiourea derivatives useful as inhibitors of viral replication
Phadke, Avinash, Quinn, Jesse, Ohkanda, Junko, Thurkauf, Andrew, Shen, Yiping, Liu, Cuixian, Chen, Dawei, and Li, Shouming
PATENT: WO 2005007601 ISSUE DATE: 20050127
APPLICATION: 2004
ASSIGNEE: (Achillion Pharmaceuticals, Inc. USA
24. 44850 OI-LS-315; WOS-OI-1/30/2005
Bovine viral diarrhoea virus is internalized by clathrin-dependent receptor-mediated endocytosis
Grummer, B, Grotha, S, and Greiser-Wilke, I
JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH 2004. 51(10): 427-432, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226093500002
25. 44851 OI-LS-315; WOS-OI-1/30/2005
Peroxiredoxin-linked detoxification of hydroperoxides in Toxoplasma gondii
Akerman, SE and Muller, S
JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(1): 564-570, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226025100067
26. 44852 OI-LS-315; WOS-OI-1/30/2005
Composition and antimicrobial activity of Achillea clavennae and Achillea holosericea essential oils
Stojanovic, G, Asakawa, Y, Palic, R, and Radulovic, N
FLAVOUR AND FRAGRANCE JOURNAL 2005. 20(1): 86-88, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226040300020
27. 44853 OI-LS-315; WOS-OI-1/30/2005
Inhibitory properties of nucleic acid-binding ligands on protein synthesis
Malina, A, Khan, S, Carlson, CB, Svitkin, Y, Harvey, I, Sonenberg, N, Beal, PA, and Pelletier, J
FEBS LETTERS 2005. 579(1): 79-89, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226170100013
28. 44854 OI-LS-315; WOS-OI-1/30/2005
A new model for utilising chemical diversity from natural sources
Buss, AD and Butler, MS
DRUG DEVELOPMENT RESEARCH 2004. 62(4): 362-370, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226158500007
29. 44855 OI-LS-315; WOS-OI-2/6/2005
Mutational dynamics in Mycobacterium tuberculosis: implications for the evolution of drug resistance
Boshoff, HIM, Barry, CE, and Mizrahi, V
SOUTH AFRICAN JOURNAL OF SCIENCE 2004. 100(9-10): 471-474, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226240500018
30. 44856 OI-LS-315; WOS-OI-2/6/2005
S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense
Rhee, KY, Erdjument-Bromage, H, Tempst, P, and Nathan, CF
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2005. 102(2): 467-472, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226315700038
31. 44857 OI-LS-315; WOS-OI-2/6/2005
The reductase steps of the type II fatty acid synthase as antimicrobial targets
Zhang, YM, Lu, YJ, and Rock, CO
LIPIDS 2004. 39 (11): 1055-1060, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226341600003
32. 44858 OI-LS-315; WOS-OI-2/6/2005
Control of hepatitis C: A medicinal chemistry perspective
Gordon, CP and Keller, PA
JOURNAL OF MEDICINAL CHEMISTRY 2005. 48(1): 1-20, 20
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226212900001
33. 44859 OI-LS-315; WOS-OI-2/6/2005
Researchers identify better hepatitis C treatment for people with HIV
Anon
JOURNAL OF INVESTIGATIVE MEDICINE 2004. 52(7): 431-432, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226188200003
34. 44860 OI-LS-315; WOS-OI-2/6/2005
Biologically active polymers: Modification and anti-microbial activity of chitosan derivatives
Kenawy, ER, Abdel-Hay, FI, Abou, El-Magd A, and Mahmoud, Y
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS 2005. 20(1): 95-111, 17
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226242200006
35. 44861 OI-LS-315; WOS-OI-2/6/2005
FR227244, a novel antifungal antibiotic from Myrothecium cinctum no. 002 - II. Biological properties and mode of action
Kobayashi, M, Sato, I, Abe, F, Nitta, K, Hashimoto, M, Fujie, A, Hino, M, and Hori, Y
JOURNAL OF ANTIBIOTICS 2004. 57(12): 788-796, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226243400003
36. 44862 OI-LS-315; WOS-OI-2/6/2005
Antifungal and anti-aflatoxinogenic activity of the brown algae Cystoseira tamarisscifolia
Zinedine, A, Elakhdari, S, Faid, M, and Benlemlih, M
JOURNAL DE MYCOLOGIE MEDICALE 2004. 14(4): 201-205, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226239700005
37. 44863 OI-LS-315; WOS-OI-2/6/2005
Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed
Lee, REB, Li, W, Chatterjee, D, and Lee, RE
GLYCOBIOLOGY 2005. 15(2): 139-151, 13
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226199900005
38. 44864 OI-LS-315; WOS-OI-2/6/2005
CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols - topological descriptors in modeling the activity
Gupta, MK, Sagar, R, Shaw, AK, and Prabhakar, YS
BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(2): 343-351, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226343800006
39. 44865 OI-LS-315; WOS-OI-2/6/2005
Antiviral and antimicrobial activities of new nitrobutane derivatives
Gokce, M, Ozcelik, B, Bakir, G, Karaoglu, T, Bercin, E, and Noyanalpan, N
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 2004. 54(12): 891-897, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226221400010
40. 44866 OI-LS-315; WOS-OI-2/6/2005
Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin
Zelezetsky, I, Pag, U, Antcheva, N, Sahl, HG, and Tossi, A
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 2005. 434(2): 358-364, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226316300017
41. 44867 OI-LS-315; WOS-OI-2/6/2005
Application of molecular genetic methods in macrolide, lincosamide and streptogramin resistance diagnostics and in detection of drug-resistant Mycobacterium tuberculosis
Jalava, J and Marttila, H
APMIS 2004. 112(11-12): 838-855, 18
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226305700009